From mucosal energy metabolism to capsaicin -strategies for understanding mucosal protection

Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment

Volumn 30, Issue , 2012, Pages 230-241

  Szabó, Imre L ^a   Czimmer, Jozsef ^a   Mózsik, Gyula ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925870616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000338463     Document Type: Chapter

References (30)

1. Selye H: Syndrome produced by diverse noxious agents. Nature 1936;138:32.
2. Robert A, Nemazis EJ, Lanchaster C, Hauchar J: Cytoprotection of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979;77:433-443.
3. Marschall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-1315.
4. Mózsik Gy, Jávor T, Dobi S: Clinical-pharmacological analysis of long term parasympatholytic treatment; in Magyar I (ed): Acta Tertii Conventus Medicinae Internae Hungarici. Gastroenterologia. Budapest, Akadémiai Kiadó, 1965, pp 709-715.
5. Mózsik Gy, Jávor T: Clinical-pharmacological testing for parasympatholytic drugs. Med Pharmacol Exp 1966;14:183-190.
6. Mózsik Gy, Jávor T,Dobi S, Petrássy K, Szabó A: Development of 'pharmacological denervation phenomenon' in patients treated with atropine. Eur J Pharmacol 1967;1:391-395.
7. Mózsik Gy, Jávor T: Development of drug crosstolerance in patients treated chronically with atropine. Eur J Pharmacol 1970;6:183-170.
8. Tárnok F, Jávor T, Mózsik Gy, Nagy L, Patty I, Rumi Gy, Solt J: A prospective, multiclinical study comparing the effects of placebo, carbenoxolone, atropine, cimetidine in patients with duodenal ulcer. Drugs Exp Clin Res 1979;5:157-166.
9. Gustfson J, Welling D: 'No acid, no ulcer' -100 years later: a review of the history of peptic ulcer disease. J Am Coll Surg 2010;210:110-116.
10. Mozsik Gy, Szabo IL, Czimmer J: Approaches to gastrointestinal cytoprotection: from isolated cells, via animal experiments in healthy human subjects and patients with different gastrointestinal disorders. Curr Pharm Dis 2011;17:1556-1572.
11. Mózsik Gy, Szabó A, Krausz M, Jávor T: Biochemical analysis of the stomach wall in normal rats. Scand J Gastroent 1967;2:321-325.
12. Mózsik Gy, Szabó A, Krausz M, Jávor T: Biochemical analysis of vagotomised stomach wall in rats. Scand J Gastroent 1967;2:326-332.
13. Mózsik Gy, Kiss B, Krausz M, Jávor T: A cellularbiochemical-morphological explanation of the development of gastric ulcer in Shay rats. Scand J Gastroent 1969;4:633-640.
14. Mózsik Gy, Kiss B, Krausz M, Jávor T: A biochemicalcellular-morphological explanation for anticholinergic effects of parasympatholytics and of surgical vagotomy. Scand J Gastroent 1969;4:461-451.
15. Mozsik Gy, Jávor T, Hauck M, Karsai T: On some cellular mechanisms of ulcer development in pylorus-ligated rats; in Pfeiffer CJ (ed): Peptic Ulcer. Philadelphia, Lippincott/Copenhagen, Munksgaard, 1971, pp 323-328.
16. +-dependent ATPase, ATP and ADP in pylorus-ligated rats. Am J Digest Dis 1976;21:649-654.
17. Mózsik Gy, Vizi F: Surgical vagotomy and stomach wall ATP and ADP in pylorus-ligated rats. Am J Digest Dis 1976;22:1072-1075.
18. Mózsik Gy, Morón F, Fiegler M, Jávor T, Nagy L, Patty I, Tárnok F: Interrelationships membranebound ATP-dependent energy systems, gastric mucosal damage produced by NaOH, hypertonic NaCl, and alcohol and prostacyclin-induced gastric cytoprotection in rats. Prostagland Leucotr Med 1983;12:4232-436.
19. + across cell membrane. Physiol Rev 1965;45:596-617.
20. Robinson GA, Bucher RW, Sutherland EW: Cyclic AMP. New York, Academic Press, 1971.
21. +-dependent ATPase from human gastric mucosa. Biophys Biochim Acta (Amsterdam) 1969;183:640-641.
22. Mózsik Gy, Morón F, Jávor T: Examination of adenyl cyclase system prepared from human gastric mucosa; in Riis P, Anthonisen P, Bagen H (eds):Advance Abstracts, 4th World Congress of Gastroenterology. Copenhagen. The Danish Gastroenterological Association. 381.
23. Mózsik Gy, Nagy L, Tárnok F, Vizi F: Gastric and small intestinal energy metabolism in mucosal damage; in Mózsik Gy, Hänninen O, Jávor T (eds):Advances in Physiological Sciences. Gastrointestinal Defence Mechanisms. Oxford, Pergamon Press, Budapest, Akadémiai Kiadó, 1981, vol 29, pp 213-276.
24. +-dependent ATPase -ADP in the rat and human gastric fundic mucosa in relation to gastric secretion; in Gáti T, Szollár LG, Ungváry Gy (eds): Advances in Physiological Sciences. Nutrition, Digestion, Metabolism. Oxford, Pergamon Press, Budapest, Akadémiai Kiadó, 1981, vol 12, pp 157-173.
25. Mózsik Gy: Molecular pharmacology and biochemistry of gastroduodenal mucosal damage and protection; in Mózsik Gy (ed): Discoveries in Gastroenterology: from Basic Sciences to Clinical Practices (1960-2005). Budapest, Akadémiai Kiadó, 2006, pp 133-218.
26. Mózsik Gy, Abdel-Salam OME, Szolcsányi J:Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Damage and Protection. Budapest, Akadémiai Kiadó, 1997.
27. Mózsik Gy, Szolcsányi J, Rácz I: Gastroprotection induced by capsaicin in healthy human subjects. World J Gastroenterol 2005;11:5180-5184.
28. Mózsik Gy, Szolcsányi J, Dömötör A: Capsaicin research as a new tool to approach of human gastrointestinal physiology, pathology and pharmacology. Inflammopharmacology 2007;15:232-245.
29. Dömötör A, Kereskai L, Szekeres Gy., Hunyady B, Szolcsányi J, Mózsik Gy: Participation of capsaicinsensitive afferent nerves in gastric mucosa of patients with Helicobacter pylori positive or negative chronic gastritis. Dig Dis Sci 2007;52:411-417.
30. Lakner L, Dömötör A, Tóth Cs, Szabo IL, Meczker Á, Hajós R, Kereskai L, Szekeres Gy, Döbrönte Z, Mózsik Gy: Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis. World J Gastroint Pharmacol Ther 2011;2:36-41.